×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| IND-SWIFT LABORATORIES LTD. | 1673.16 | 87.75 | 1527.34 | 1.17 | 784.0 | 35.6 |
| Shree Ganesh Remedies Limited | NA | NA | NA | NA | 754 | 34.5 |
| Prevest Denpro Limited | NA | NA | NA | NA | 668 | 35.3 |
Ind-Swift Laboratories Ltd., with Security Code 532305, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 302.4 | 290.5 | 299.0 | 270.3 | 276.3 | 381.7 | 30.5 | 2.7 | 1.4 | 148.0 |
| Expenses | 246.5 | 234.1 | 239.2 | 206.9 | 222.5 | 286.3 | 35.0 | 14.7 | 10.2 | 144.9 |
| Operating Profit | 55.9 | 56.3 | 59.8 | 63.4 | 53.8 | 95.5 | -4.5 | -12.0 | -8.8 | 3.1 |
| OPM % | 18.49% | 19.4% | 20% | 23.46% | 19.48% | 25.01% | -14.88% | -443.39% | -625.99% | 2.08% |
| Other Income | 8.4 | -16.7 | 5.6 | 7.4 | 7.1 | 411.8 | 11.1 | 12.9 | 13.8 | 14.6 |
| Interest | 22.4 | 21.8 | 20.4 | 21.1 | 21.1 | 11.5 | 0.2 | 0.4 | 0.1 | 1.2 |
| Depreciation | 15.4 | 9.3 | 13.9 | 13.2 | 13.6 | 12.7 | 0.3 | 0.2 | 0.2 | 6.7 |
| Profit before tax | 26.5 | 35.2 | 31.1 | 36.5 | 26.3 | 96.6 | 6.2 | 0.3 | 4.6 | 9.8 |
| Tax % | 10.4% | -460.5% | -17.5% | -17.5% | -17.7% | -27.6% | 0% | 0% | 0% | 17.4% |
| Net Profit | 29.2 | -30.9 | 17.1 | 30.1 | 21.7 | 349.6 | 6.2 | 0.3 | 4.6 | 8.1 |
| EPS in Rs | 4.95 | -5.23 | 2.89 | 5.09 | 3.66 | 59.17 | 1.05 | 0.05 | 0.78 | 1.08 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 312.7 | 304.2 | 310.3 | 289.7 | 287.5 | 393.3 | 33.2 | 12.0 | 8.7 | 152.7 |
| Expenses | 259.0 | 239.6 | 250.2 | 224.2 | 236.4 | 407.7 | 43.0 | 23.8 | 23.2 | 149.1 |
| Operating Profit | 53.6 | 64.6 | 60.1 | 65.5 | 51.2 | -14.4 | -9.8 | -11.8 | -14.5 | 3.6 |
| OPM % | 17.16% | 21.25% | 19.38% | 22.62% | 17.79% | -3.65% | -29.59% | -98.63% | -167.72% | 2.36% |
| Other Income | 8.4 | -16.4 | 5.6 | 7.4 | 7.1 | 411.8 | 11.1 | 13.0 | 13.8 | 14.6 |
| Interest | 22.4 | 21.8 | 20.4 | 21.1 | 21.1 | 11.5 | 0.2 | 0.4 | 0.1 | 1.2 |
| Depreciation | 15.4 | 9.3 | 13.9 | 13.2 | 13.6 | 12.7 | 0.3 | 0.2 | 0.2 | 6.7 |
| Profit before tax | 24.2 | 43.7 | 31.5 | 38.6 | 23.7 | -13.3 | 0.9 | 0.6 | -1.1 | 10.4 |
| Tax % | 13.4% | -239.9% | -17.8% | -17.9% | -17.9% | -36% | -3% | -31.7% | 99.5% | 16.5% |
| Net Profit | 27.5 | -24.1 | 17.2 | 31.7 | 19.4 | 238.9 | 0.9 | 0.4 | 0.0 | 8.8 |
| EPS in Rs | 4.65 | -4.08 | 2.92 | 5.36 | 3.29 | 40.42 | 0.16 | 0.07 | 0 | 1.17 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| TTM: | -63% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 48% |
| 3 Years: | 222% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 25% |
| 3 Years: | 6% |
| 1 Year: | -32% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| TTM: | -62% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 42% |
| 3 Years: | 260% |
| TTM: | 188% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 25% |
| 3 Years: | 6% |
| 1 Year: | -32% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|